From: A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro and in vivo
Groups
HT-29
HDLECs
Co-culture
G2/M
S
Control
25.5 ± 3.3
21.7 ± 3.1
16.5 ± 2.3
16.7 ± 2.3
21.5 ± 3.3
18.9 ± 3.0
NCTD (IC50)
28.7 ± 4.8
9.3 ± 1.8*
15.7 ± 2.8*
6.3 ± 1.2*
22.7 ± 2.8*
7.8 ± 1.6*